281 related articles for article (PubMed ID: 17277134)
1. Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis.
Stel AJ; Ten Cate B; Jacobs S; Kok JW; Spierings DC; Dondorff M; Helfrich W; Kluin-Nelemans HC; de Leij LF; Withoff S; Kroesen BJ
J Immunol; 2007 Feb; 178(4):2287-95. PubMed ID: 17277134
[TBL] [Abstract][Full Text] [Related]
2. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
Vega MI; Huerta-Yepez S; Jazirehi AR; Garban H; Bonavida B
Oncogene; 2005 Dec; 24(55):8114-27. PubMed ID: 16103877
[TBL] [Abstract][Full Text] [Related]
3. Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells.
Shan D; Ledbetter JA; Press OW
Cancer Immunol Immunother; 2000 Mar; 48(12):673-83. PubMed ID: 10752475
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
[TBL] [Abstract][Full Text] [Related]
5. CD20-induced B cell death can bypass mitochondria and caspase activation.
van der Kolk LE; Evers LM; Omene C; Lens SM; Lederman S; van Lier RA; van Oers MH; Eldering E
Leukemia; 2002 Sep; 16(9):1735-44. PubMed ID: 12200688
[TBL] [Abstract][Full Text] [Related]
6. Fas aggregation does not correlate with Fas-mediated apoptosis.
Lee Y; Shacter E
J Immunol; 2001 Jul; 167(1):82-9. PubMed ID: 11418635
[TBL] [Abstract][Full Text] [Related]
7. Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate.
Sieber S; Gdynia G; Roth W; Bonavida B; Efferth T
Int J Oncol; 2009 Jul; 35(1):149-58. PubMed ID: 19513562
[TBL] [Abstract][Full Text] [Related]
8. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
[TBL] [Abstract][Full Text] [Related]
9. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
10. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.
Wieder T; Essmann F; Prokop A; Schmelz K; Schulze-Osthoff K; Beyaert R; Dörken B; Daniel PT
Blood; 2001 Mar; 97(5):1378-87. PubMed ID: 11222383
[TBL] [Abstract][Full Text] [Related]
11. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
Moriyama H; Yonehara S
Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
[TBL] [Abstract][Full Text] [Related]
12. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
[TBL] [Abstract][Full Text] [Related]
13. Feedback regulation of mitochondria by caspase-9 in the B cell receptor-mediated apoptosis.
Eeva J; Nuutinen U; Ropponen A; Mättö M; Eray M; Pellinen R; Wahlfors J; Pelkonen J
Scand J Immunol; 2009 Dec; 70(6):574-83. PubMed ID: 19906200
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
15. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
16. Cytokine regulation of human intestinal primary epithelial cell susceptibility to Fas-mediated apoptosis.
Martin CA; Panja A
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G92-G104. PubMed ID: 11751162
[TBL] [Abstract][Full Text] [Related]
17. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells.
Mueller CM; Scott DW
J Immunol; 2000 Aug; 165(4):1854-62. PubMed ID: 10925264
[TBL] [Abstract][Full Text] [Related]
18. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
19. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.
Liu C; DeNardo G; Tobin E; DeNardo S
Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447
[TBL] [Abstract][Full Text] [Related]
20. Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells.
Droin N; Bichat F; Rébé C; Wotawa A; Sordet O; Hammann A; Bertrand R; Solary E
Blood; 2001 Mar; 97(6):1835-44. PubMed ID: 11238127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
